PMID- 29054819 OWN - NLM STAT- MEDLINE DCOM- 20180710 LR - 20181201 IS - 1873-5177 (Electronic) IS - 0091-3057 (Print) IS - 0091-3057 (Linking) VI - 163 DP - 2017 Dec TI - High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration. PG - 38-49 LID - S0091-3057(17)30470-7 [pii] LID - 10.1016/j.pbb.2017.10.008 [doi] AB - RATIONALE: MDMA alters body temperature in rats with a direction that depends on the ambient temperature (T(A)). The thermoregulatory effects of MDMA and T(A) may affect intravenous self-administration (IVSA) of MDMA but limited prior reports conflict. OBJECTIVE: To determine how body temperature responses under high and low T(A) influence MDMA IVSA. METHODS: Male Sprague-Dawley rats were trained to IVSA MDMA (1.0mg/kg/infusion; 2-h sessions; FR5 schedule of reinforcement) under T(A) 20 degrees C or 30 degrees C. Radiotelemetry transmitters recorded body temperature and activity during IVSA. RESULTS: MDMA intake increased under both T(A) during acquisition, but to a greater extent in the 30 degrees C group. The magnitude of hypothermia was initially equivalent between groups but diminished over training in the 30 degrees C group. Within-session activity was initially lower in the 30 degrees C group, but by the end of acquisition and maintenance, activity was similar for both groups. When T(A) conditions were swapped, the hot-trained group increased MDMA IVSA under 20 degrees C T(A) and a modest decrease in drug intake was observed in the cold-trained group under 30 degrees C T(A). Subsequent non-contingent MDMA (1.0-5.0mg/kg, i.v.) found that rats with higher MDMA IVSA rates showed blunted hypothermia compared with rats with lower IVSA levels; however, within-session activity did not differ by group. High T(A) increased intracranial self-stimulation thresholds in a different group of rats and MDMA reduced thresholds below baseline at low, but not high, T(A). CONCLUSIONS: High T(A) appears to enhance acquisition of MDMA IVSA through an aversive effect and not via thermoregulatory motivation. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Aarde, Shawn M AU - Aarde SM AD - Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. FAU - Huang, Pai-Kai AU - Huang PK AD - Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. FAU - Taffe, Michael A AU - Taffe MA AD - Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. Electronic address: mtaffe@scripps.edu. LA - eng GR - R01 DA024105/DA/NIDA NIH HHS/United States GR - R01 DA042211/DA/NIDA NIH HHS/United States PT - Journal Article DEP - 20171017 PL - United States TA - Pharmacol Biochem Behav JT - Pharmacology, biochemistry, and behavior JID - 0367050 RN - 0 (Hallucinogens) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Hallucinogens/*administration & dosage MH - *Hot Temperature MH - Locomotion/drug effects MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*administration & dosage MH - Rats MH - Rats, Sprague-Dawley MH - Self Administration PMC - PMC5688002 MID - NIHMS916214 OTO - NOTNLM OT - Ecstasy OT - Reward OT - Thermoregulation EDAT- 2017/10/22 06:00 MHDA- 2018/07/11 06:00 PMCR- 2018/12/01 CRDT- 2017/10/22 06:00 PHST- 2017/08/01 00:00 [received] PHST- 2017/09/19 00:00 [revised] PHST- 2017/10/16 00:00 [accepted] PHST- 2017/10/22 06:00 [pubmed] PHST- 2018/07/11 06:00 [medline] PHST- 2017/10/22 06:00 [entrez] PHST- 2018/12/01 00:00 [pmc-release] AID - S0091-3057(17)30470-7 [pii] AID - 10.1016/j.pbb.2017.10.008 [doi] PST - ppublish SO - Pharmacol Biochem Behav. 2017 Dec;163:38-49. doi: 10.1016/j.pbb.2017.10.008. Epub 2017 Oct 17.